
David Lyden MD
Associate Professor, Pediatrics, Weill Cornell Medical College
Join to View Full Profile
413 East 69th StNew York, NY 10021
Phone+1 212-639-2152
Dr. Lyden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1992 - 1995
- Duke University HospitalResidency, Pediatrics, 1989 - 1992
- The Warren Alpert Medical School of Brown UniversityClass of 1989
Certifications & Licensure
- NY State Medical License 1992 - 2026
Publications & Presentations
PubMed
- Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, Gautam Sule, Carmelo Carmona-Rivera
JCI Insight. 2025-04-01 - Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2.Serena Lucotti, Yusuke Ogitani, Candia M Kenific, Jacob Geri, Young Hun Kim
Cell. 2025-03-20 - 2 citationsUnique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression.Inbal Wortzel, Yura Seo, Ife Akano, Lee Shaashua, Gabriel Cardial Tobias
Nature Cancer. 2024-12-01
Journal Articles
- Complex Polymorphisms in Endocytosis Genes Suggest Alpha-Cyclodextrin as a Treatment for Breast CancerDavid Lyden, MD, PLoS One
Press Mentions
- Cancer’s Ripple Effect May Promote Blood Clots in LungsFebruary 12th, 2025
- Lung Signals Trigger Blood Clot Formation in Cancer PatientsFebruary 10th, 2025
- DNA Secreted by Tumour Cell Extracellular Vesicles Prompts Anti-Metastatic Immune ResponseDecember 4th, 2024
- Join now to see all
Grant Support
- Regulation Of Tumor Angiogenesis By Id+ Marrow PrecursorNational Cancer Institute2003–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: